[Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
作者信息
Haubenstock A, Schmidt P, Zazgornik J, Balcke P, Kopsa H, Sertl K
出版信息
Dtsch Med Wochenschr. 1984 Jan 27;109(4):157-8.
PMID:6692783
Abstract
摘要
相似文献
1
[Bezafibrate-induced rhabdomyolysis in a patient with impaired kidney function].
Dtsch Med Wochenschr. 1984 Jan 27;109(4):157-8.
2
[Bezafibrate myopathy in two patients with chronic renal failure].
Rinsho Shinkeigaku. 1992 Jul;32(7):725-8.
3
Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
Am J Kidney Dis. 2005 Mar;45(3):e57-60. doi: 10.1053/j.ajkd.2004.12.003.
4
[Bezafibrate-induced myoglobinuric kidney failure in a 54-year-old patient with diabetes mellitus type IIa].
Med Klin (Munich). 1988 Mar 4;83(5):174-7.
5
[A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate].
Minerva Med. 1990 Dec;81(12):909-11.
6
Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?腹膜透析患者中因苯扎贝特导致的横纹肌溶解症。二氢吡啶类药物起了什么作用？
Perit Dial Int. 1999 Mar-Apr;19(2):180-2.
7
[Rhabdomyolysis and acute renal failure secondary to statins].[他汀类药物继发横纹肌溶解症和急性肾衰竭]
Nefrologia. 2001 May-Jun;21(3):309-13.
8
Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
Singapore Med J. 2001 Aug;42(8):368-72.
9
[Case of secondary carnitine deficiency (in a patient undergoing hemodialysis), developing rhabdomyolysis due to dehydration and the action of a hypolipemic agent].[继发性肉碱缺乏病例（在一名接受血液透析的患者中），因脱水和一种降血脂药物的作用而发生横纹肌溶解]
Nihon Naika Gakkai Zasshi. 1993 Dec 10;82(12):2066-7.
10
[Rhabdomyolysis due to bezafibrate: a new case].
Med Clin (Barc). 1992 Feb 1;98(4):156-7.
引用本文的文献
1
Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.药物性横纹肌溶解症的临床特征、发病机制及治疗
Med Toxicol Adverse Drug Exp. 1989 Mar-Apr;4(2):108-26. doi: 10.1007/BF03259907.
Zotero 插件